200 results
Page 2 of 10
8-K
EX-99.2
rphmvl4mo
30 Nov 23
AbbVie to Acquire ImmunoGen, including its Flagship Cancer Therapy ELAHEREĀ® (mirvetuximab soravtansine-gynx), Expanding Solid Tumor Portfolio
8:47am
SD
EX-1.01
slf pi4s08eiz
31 May 23
Conflict minerals disclosure
4:59pm
8-K
9a3ow1ed
10 May 23
Submission of Matters to a Vote of Security Holders
5:10pm
PX14A6G
vlz3amjl r3ke7zfyi
20 Apr 23
Letter to shareholders
3:39pm
8-K
iwob68
14 Oct 22
Departure of Directors or Certain Officers
5:02pm
8-K
EX-3.1
ry49pfpiv54jo21fgou
14 Oct 22
Departure of Directors or Certain Officers
5:02pm
8-K
EX-10.1
llkhv2 ws
14 Oct 22
Departure of Directors or Certain Officers
5:02pm
8-K
EX-3.1
m7aa5yfk z2
29 Jun 22
Amendments to Articles of Incorporation or Bylaws
8:30am
SD
EX-1.01
zfe621j56lu
31 May 22
Conflict minerals disclosure
5:01pm
PX14A6G
a21a0hqm5puw6kbp1pu
4 Apr 22
Letter to shareholders
8:36am
S-3ASR
EX-25.1
noisp1tzissjvd9kn
22 Feb 22
Automatic shelf registration
5:02pm